399. Deputy Ryan O'Meara asked the Minister for Health her plans to expand the conditions covered under the long-term illness scheme; if consideration is being given to the inclusion of Crohn’s disease and other inflammatory bowel diseases due to their lifelong nature and ongoing treatment requirements. [74950/26]
Topics / Disease Management
A subject heading for parliamentary questionsDisease Management
241 questions from 71 TDs, between 22 January 2025 and 22 October 2026.
241
questions
239 written, 2 oral
71
TDs have asked
10
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 1 |
| February 2025 | 4 |
| March 2025 | 21 |
| April 2025 | 4 |
| May 2025 | 29 |
| June 2025 | 9 |
| July 2025 | 6 |
| August 2025 | 0 |
| September 2025 | 4 |
| October 2025 | 33 |
| November 2025 | 16 |
| December 2025 | 5 |
| January 2026 | 4 |
| February 2026 | 3 |
| March 2026 | 16 |
| April 2026 | 24 |
| May 2026 | 28 |
| June 2026 | 10 |
| July 2026 | 13 |
| August 2026 | 0 |
| September 2026 | 7 |
| October 2026 | 4 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
40
-
18
-
16
-
14
-
13
-
10
-
7
-
7
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
940. Deputy Ivana Bacik asked the Minister for Health if she will make a statement on the description by a person (details supplied) of the "urgent" need for a funded care pathway for Huntington's disease in a recent case. [74361/26]
954. Deputy Denise Mitchell asked the Minister for Health if she will ensure that appropriate funding is available to the HSE to ensure the implementation of the Huntington's Disease care pathway and to enable the appointment of additional HD specialist nurses and the uplifting of multidisciplinary teams in all neurology centres in each health region; and if she will make a statement on the matter. [74394/26]
592. Deputy Ivana Bacik asked the Minister for Health for an update on the care pathway for Huntington's disease. [70054/26]
720. Deputy John McGuinness asked the Minister for Health if the provision for reimbursement support under the community drug scheme for a continuous glucose monitoring device will be extended beyond patients with type 1 diabetes to include patients with reactive hypoglycaemia; the number of patients affected by hypoglycaemia; and the estimated cost of including this cohort; and if she will make a statement on the ma…
731. Deputy John McGuinness asked the Minister for Health the services that are available to Parkinson’s patients in the South East; and if she will make a statement on the matter. [68160/26]
538. Deputy Erin McGreehan asked the Minister for Health if she will expand the Chronic Disease Management Programme to all adults with eligible chronic conditions, regardless of whether they hold a medical card or GP visit card; and the estimated cost and timeframe for implementing this expansion. [66409/26]
420. Deputy John Clendennen asked the Minister for Health for an update on the development and implementation of a national care pathway for Huntington's disease, including the estimated annual cost of fully implementing the proposed pathway; and whether funding has been sought for implementation in 2026 and 2027. [66287/26]
421. Deputy John Clendennen asked the Minister for Health whether the proposed national care pathway for Huntington's disease provides for the establishment of regional specialist multidisciplinary services; the proposed number and locations of such services; and the disciplines that will comprise each multidisciplinary team. [66286/26]
1280. Deputy Denise Mitchell asked the Minister for Health the progress made on a national care pathway to help those diagnosed with Huntington’s disease; the additional resources and staffing that will be made available to support patients diagnosed with this disease; when it is expected a national care pathway for this disease will be implemented; and if she will make a statement on the matter. [64955/26]
1290. Deputy Tom Brabazon asked the Minister for Health if her Department will introduce a funding pathway for Huntington's disease care. [64966/26]
866. Deputy Keira Keogh asked the Minister for Health for an update on her Department's engagement with parents of children who they suspect suffer from PANS-PANDAS; the measures her Department is taking to develop guidelines; and if she will make a statement on the matter. [53347/26]
278. Deputy Emer Currie asked the Minister for Health to outline Government policy on access to continuous glucose monitoring devices for people with type two diabetes; whether she will request a rapid health technology assessment to inform future eligibility and reimbursement; if so, the expected timeline for same; and if she will make a statement on the matter. [49946/26]
279. Deputy Emer Currie asked the Minister for Health having regard to her responsibility for national diabetes policy, the steps she is taking to ensure that the HSE publishes the outcome of the preferred sensor exercise, which was due in the first quarter of 2026; the revised publication date; and if she will make a statement on the matter. [49947/26]
309. Deputy Erin McGreehan asked the Minister for Health the current status of the health technology assessment and reimbursement decision for pluvicto (lutetium-177 PSMA therapy) for the treatment of metastatic castration-resistant prostate cancer; the timeline for a final determination; and if she will make a statement on the matter. [50111/26]
310. Deputy Erin McGreehan asked the Minister for Health the steps being taken to ensure Irish patients have timely and equitable access to innovative oncology treatments, including radioligand therapies such as pluvicto; and the way Ireland compares with other EU Member States in access to such treatments. [50112/26]
311. Deputy Erin McGreehan asked the Minister for Health the current capacity within the public health system to deliver radioligand therapies, including the availability of nuclear medicine facilities, trained personnel, and radiopharmacy supports; and the plans in place to expand this capacity. [50113/26]
312. Deputy Erin McGreehan asked the Minister for Health whether her Department has undertaken or commissioned any strategic review of Ireland's nuclear medicine and radiopharmacy infrastructure; and the actions planned to develop a sustainable, indigenous capability in this area. [50114/26]
313. Deputy Erin McGreehan asked the Minister for Health if consideration is being given to developing a national strategy for radiopharmaceutical production and usage, in light of increasing global demand and supply constraints; and if she will outline any engagement with industry, academia, or international partners on this issue. [50115/26]
314. Deputy Erin McGreehan asked the Minister for Health the level of capital and operational investment allocated to nuclear medicine and advanced cancer therapies over the past five years; and the projected investment over the next five years to support emerging treatments such as radioligand therapies. [50116/26]
315. Deputy Erin McGreehan asked the Minister for Health the current number of specialists in nuclear medicine, radiopharmacy, and medical physics in Ireland; the projected workforce requirements to support expansion in radioligand therapies; and the plans to address any identified gaps. [50117/26]
316. Deputy Erin McGreehan asked the Minister for Health the supports in place to enable Irish participation in international clinical trials involving radiopharmaceuticals and targeted radionuclide therapies; and the way in which Ireland can position itself as a hub for such research. [50118/26]
317. Deputy Erin McGreehan asked the Minister for Health the extent of engagement with patient advocacy organisations, including those representing prostate cancer patients, in relation to the reimbursement and provision of new treatments such as pluvicto. [50119/26]
318. Deputy Erin McGreehan asked the Minister for Health if she will support a dedicated session of the relevant Oireachtas Committee to examine the case for investment in nuclear medicine and radiopharmacy infrastructure, including emerging cancer therapies; and if officials from her Department would be available to attend. [50120/26]
924. Deputy Michael Lowry asked the Minister for Health the reasons Crohn's disease is not included among the conditions covered under the long-term illness scheme; whether consideration has been given to extending eligibility for a long-term illness card to persons living with Crohn's disease and other chronic lifelong conditions that require ongoing medication, treatment and monitoring; and if she will make a state…